Temple Hematology

Temple Faculty Practice Plan
Department of Medicine
Section of Hematology

[Temple Hematology @TempleHeme]

Second-year hematology fellow, Dr. Mazidi, giving a lecture on Von Willebrand disease for our internal medicine residents #hematology #TempleHospital #TUHS

[Temple Hematology @TempleHeme]

Incredibly honored and elated to announce that the Temple hematology team was accepted to participate in the @ASH_hematology Sickle Cell Disease Centers Workshop in 2022! So excited to better serve the community in North Philadelphia! #SCD @TempleHealth

[Samer Al Hadidi, MD,MS,FACP @HadidiSamer]

How I Treat AL Amyloidosis @BloodJournal | @ASH_hematology
#MMsm
➡️ Nice practical review,summary tables&suggested treatment algorithms with 5 cases
➡️Link: https://t.co/jfLJz8Uiib
🛑 it is amazing how science is advancing.Doxycycline study mentioned👇 just reported as negative

[Temple Hematology @TempleHeme]

We’re back to learning in person this semester! Masked of course. HITT and VITT lecture by Dr. Rao. #HITT #VITT

[Lachelle Dawn @Lachelle_Dawn]

First live study session for the 2021 @ASH_Hematology Board Review Series is tonight at 6pm!

Join Drs Bauer, Schaefer, Ma and myself as we work through multiple choice questions on #coagulation #hemostasis and #thrombosis.

Come study with me! (link below) 🤓

[Lachelle Dawn @Lachelle_Dawn]

Friends: I am so proud of @ASH_hematology and out Anti-Racism Task Force for creating a statement on the risk of sudden death with #sicklecell trait.

You can read the statement here:

https://t.co/sZ0cnV3Nso

[ASH @ASH_hematology]

In response to a recent @nytimes investigation, we have updated our position statement on #sicklecell trait and will focus on education and training to end this injustice. Read more: https://t.co/NyznrAQxig

[Temple Hematology @TempleHeme]

Hematology Faculty Dr. Ali and Dr. Bromberg proud to have received the COVID-19 vaccine today! #ThisIsOurShot #Covid19vaccine #science

[Temple Hematology @TempleHeme]

Fantastic tweetorial on diffuse large B cell lymphoma!

[Fernand Bteich, MD, MS @fernandbteich]

1/ Now that #ASH20 is happening, I decided to present common hematologic malignancies in #Tweetorial fashion with advice on how an #internist can help with workup and treatment.

Today is Diffuse large B-cell lymphoma (#DLBCL)'s turn!

🧵

[Temple Hematology @TempleHeme]

Consult for thrombocytopenia, rule out HIT. What’s the first thing to do? Print out the platelet trend and calculate the 4T score! Nice work Dr. David Xu, 2nd year Heme/Onc fellow. Ideally calculate the 4T score BEFORE sending the HIT antibody.

[Temple Hematology @TempleHeme]

Happy Birthday Dr. Bromberg! Our fearless leader. He’s busy doing telemedicine.

[Temple Hematology @TempleHeme]

Finishing up Friday afternoon rounds with Dr. Paul Ehrlichman, PGY4 and Tamsin, MS3. When it is appropriate to do a hypercoaguable work up inpatient? #ASHchoosingwisely

[Nadia Dawn Ali, MD @nadiadawnali]

VTE incidence of 3.5% at Temple in our COVID unit in ~ 700 pts at the beginning of the pandemic. Our single institution real world experience.

[Temple Hematology @TempleHeme]

We’re happy to have medical students back on Hematology consults, especially when they are as awesome as Sam Black, MS4! His visual figure analyzing thrombocytopenia is #hematologyconsultgoals @templemedschool

[Temple Hematology @TempleHeme]

We’re so glad to call Maria a colleague! She does a fantastic job with our patients with Heme malignancies!

[Gerardo Hernández, CHI-Spanish @GHernandezNet]

Congratulations to Maria Rodriguez (nurse navigator and medical interpreter at @TempleHealth cancer center in Philadelphia, Pennsylvania) for being named a finalist for @cure_magazine's 2020 #ExtraordinaryHealer Award for Oncology Nursing! https://t.co/ojJWIkGTzm

[Temple Hematology @TempleHeme]

COVID19 Associated Hypercoaguable State #CAHS is what we are calling the hypercoaguable state we are seeing in patients with #COVID19

[J Mark Sloan @Jmarksloan]

I just finished reviewing the #COVID anticoagulation protocols at several different academic medical centers. Here is a summary. @connors_md @MaryCushmanMD @AggieLeeMD

[Temple Hematology @TempleHeme]

Very important thread. This is exactly what we have been seeing in COVID19 patients here.

[Scott Gottlieb, MD 🇺🇸 @ScottGottliebMD]

THREAD: There's a growing body of data to strongly suggest #COVID19 predisposes to both venous and arterial thromboembolism due to excessive inflammation, hypoxia, immobilization and diffuse intravascular coagulation. This may explain some of rapid decline patients experience 1/n

[Temple Hematology @TempleHeme]

The Heme team calling patients who are high risk for COVID-19 and telling them to stay home from clinic as we will be practicing tele-medicine to reduce exposure! #CoronavirusPandemic #lifeinthetimeofcovid

[Temple Hematology @TempleHeme]

Patients ill from COVID-19 who present with DIC have a much higher mortality rate. Important to keep in mind to check coags, fibrinogen, platelets and d-dimer when assessing critically ill patients.